Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.

Slides:



Advertisements
Similar presentations
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.
Advertisements

Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Usual Blood Pressure and Risk of New-Onset Diabetes:
From: Genetic Inhibition of CETP, Ischemic Vascular Disease and Mortality, and Possible Adverse Effects J Am Coll Cardiol. 2012;60(20): doi: /j.jacc
Natalie Staplin, PhD, Richard Haynes, DM, William G
Copyright © 2014 American Medical Association. All rights reserved.
Urine Potassium Excretion, Kidney Failure, and Mortality in CKD
Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese.
Chronic Kidney Disease in Diabetes
Copyright © 2012 American Medical Association. All rights reserved.
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies  Mehran Rahimlu, MSc, Sakineh.
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Association Between Sonographically Diagnosed Nephrolithiasis and Subclinical Coronary Artery Calcification in Adults  Seolhye Kim, Yoosoo Chang, Eunju.
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
Volume 375, Issue 9709, Pages (January 2010)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Volume 93, Issue 4, Pages (April 2018)
Natalie Staplin, PhD, Richard Haynes, DM, William G
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)  Borislava.
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Natalie Staplin, PhD, Richard Haynes, DM, William G
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study  Digsu.
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)  Richard.
Volume 93, Issue 5, Pages (May 2018)
Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study  William.
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study  Trine Moholdt,
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
Volume 379, Issue 9822, Pages (March 2012)
Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study  Martin J. Landray, PhD,
Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis  Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,
Volume 79, Pages S9-S13 (April 2011)
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis  Kevin Quach,
Volume 68, Issue 6, Pages (December 2005)
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Stephen P. McDonald  Kidney International Supplements 
Body-mass index, blood pressure, and cause-specific mortality in India: a prospective cohort study of 500 810 adults  Vendhan Gajalakshmi, PhD, Ben Lacey,
American Journal of Kidney Diseases
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS)  Michelle.
Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized Trial  Delphine S. Tuot, Charles E.
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Volume 86, Issue 3, Pages (September 2014)
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease  Iryna Schlackow, Seamus Kent, William Herrington, Jonathan Emberson,
Volume 379, Issue 9822, Pages (March 2012)
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings.
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Volume 87, Issue 1, Pages (January 2015)
Sodium Intake and Mortality in the NHANES II Follow-up Study
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Volume 73, Issue 8, Pages (April 2008)
Volume 64, Issue 2, Pages (August 2003)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers  Paolo Palatini, MD, Claudio Fania, MD, Lucio Mos,
Volume 75, Issue 1, Pages (January 2009)
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Friends, social networks, and progressive chronic kidney disease
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair Gray, PhD, Alan Cass, PhD, Richard Haynes, DM, FRCP, Jonathan Emberson, PhD, William Herrington, MD, Martin J. Landray, PhD, FRCP, Colin Baigent, FRCP, Borislava Mihaylova, DPhil  American Journal of Kidney Diseases  Volume 67, Issue 1, Pages 31-39 (January 2016) DOI: 10.1053/j.ajkd.2015.07.021 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Relevance of highest education level attained to 2,317 vascular events (atherosclerotic and nonatherosclerotic). (A) Total effect: Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. Test for trend χ2=16.12; P<0.001. (B) Residual effect: Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, smoking, alcohol use, body mass index, chronic kidney disease stage, prior vascular disease, diabetes, renal diagnosis, systolic and diastolic blood pressure, albumin level, urinary albumin-creatinine ratio, hemoglobin level, phosphate level, high-density lipoprotein cholesterol level, and total cholesterol level. The size of the square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in the models were evaluated after excluding participants with unrecorded education. Test for trend χ2=0.81; P=0.4. American Journal of Kidney Diseases 2016 67, 31-39DOI: (10.1053/j.ajkd.2015.07.021) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Relevance of highest education level attained to vascular, nonvascular, and overall mortality. (A) Total effects: Cox proportional hazards models stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. Tests for trend: χ2=14.23; P<0.001 for vascular deaths; χ2=29.42; P<0.001 for nonvascular deaths; χ2=51.52; P<0.001 for all deaths. (B) Residual effects: Cox proportional hazards models stratified by country and adjusted for age, sex, black ethnicity, study treatment assignment, smoking, alcohol use, body mass index, chronic kidney disease stage, prior vascular disease, diabetes, renal diagnosis, systolic and diastolic blood pressure, albumin level, urinary albumin-creatinine ratio, hemoglobin level, phosphate level, high-density lipoprotein cholesterol level, and total cholesterol level. The size of a square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in all models were evaluated after excluding participants with unrecorded education. Tests for trend: χ2=2.76; P=0.1for vascular deaths; χ2=9.18; P=0.003 for nonvascular deaths; χ2=15.09; P<0.001 for all deaths. American Journal of Kidney Diseases 2016 67, 31-39DOI: (10.1053/j.ajkd.2015.07.021) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Relevance of highest education level attained among 6,245 participants not on dialysis therapy at randomization to progression to end-stage renal disease or doubling of creatinine level. Participants with end point, n=2,446. Test for trend, Wald χ2=0.71; P=0.4. Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. The size of the square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in all models were evaluated after excluding participants with unrecorded education. American Journal of Kidney Diseases 2016 67, 31-39DOI: (10.1053/j.ajkd.2015.07.021) Copyright © 2016 The Authors Terms and Conditions